Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Product Outlook
2.3. Application Outlook
2.4. Regional Outlook
Chapter 3. Brain Health Supplements Market Variables, Trends & Scope
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Sales/Retail Channel Analysis
3.3.2. Profit Margin Analysis
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5. Business Environment Analysis
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrants
3.5.1.5. Competitive Rivalry
3.6. Roadmap of the Brain Health Supplements Market
3.7. Market Entry Strategies
3.8. Impact of COVID-19 on the Brain Health Supplements Market
Chapter 4. Consumer Behavior Analysis
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
Chapter 5. Brain Health Supplements Market: Product Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2022 & 2030
5.2. Natural Molecules
5.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.2.2. Acetyl-L-Carnitine
5.2.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.2.3. Citicolin
5.2.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.2.4. DHA
5.2.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.2.5. Pre/Pro/Postbiotics
5.2.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.2.6. Others
5.2.6.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.3. Herbal Extracts
5.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.3.2. Ginseng
5.3.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.3.3. Gingko Biloba
5.3.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.3.4. Curcumin
5.3.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.3.5. Others
5.3.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.4. Vitamins & Minerals
5.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.4.2. Vitamin B
5.4.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.4.3. Vitamin C & E
5.4.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
Chapter 6. Brain Health Supplements Market: Application Estimates & Trend Analysis
6.1. Application Movement Analysis & Market Share, 2022 & 2030
6.2. Memory Enhancement
6.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
6.3. Attention & Focus
6.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
6.4. Depression & Mood
6.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
6.5. Sleep & Recovery
6.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
6.6. Anti-aging & Longevity
6.6.1. Market estimates and forecast, 2017 – 2030 (USD Million)
6.7. Stress & Anxiety
6.7.1. Market estimates and forecast, 2017 – 2030 (USD Million)
Chapter 7. Brain Health Supplements Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2022 & 2030
7.2. North America
7.2.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.2.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.2.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.2.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.2.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.2.5. Canada
7.2.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.2.5.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.2.5.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.3.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.3.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.3.4. U.K.
7.3.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.3.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.3.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.3.5. Germany
7.3.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.3.5.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.3.5.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.3.6. France
7.3.6.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.3.6.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.3.6.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.3.7.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.3.7.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.4.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.4.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.4.5. China
7.4.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.4.5.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.4.5.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.4.6. Japan
7.4.6.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.4.6.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.4.6.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.4.7.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.4.7.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.5.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.5.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.5.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.5.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.6.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.6.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. Market estimates and forecast, 2017 – 2030 (USD Million)
7.6.4.2. Market estimates and forecast, by product, 2017 – 2030 (USD Million)
7.6.4.3. Market estimates and forecast, by application, 2017 – 2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Key global players, recent developments & their impact on the industry
8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2022
Chapter 9. Company Profiles
9.1. Natural Factors Nutritional Products Ltd.
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Onnit Labs, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Purelife Bioscience Co., Ltd.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Intelligent Labs
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Accelerated Intelligence Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. NOW Foods
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. HVMN Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Teva Pharmaceutical Industries Ltd.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Peak Nootropics
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
9.10. Alternascript
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives